Valuation: Camlin Fine Sciences Limited

Market Cap 1.82TCr 19Cr 17Cr 16Cr 14Cr 27Cr 27Cr 189.1Cr 73Cr 930.52Cr 71Cr 69Cr 2.99TCr P/E 2027 *
23.7x
P/E 2028 * 11.6x
Enterprise Value 1.82TCr 19Cr 17Cr 16Cr 14Cr 27Cr 27Cr 189.1Cr 73Cr 930.52Cr 71Cr 69Cr 2.99TCr EV / Sales 2027 *
0.85x
EV / Sales 2028 * 0.77x
Free-Float
55.75%
Yield 2027 *
-
Yield 2028 * -
1 day+4.02%
1 week-0.62%
Current month+2.00%
1 month-7.94%
3 months-30.57%
6 months-8.04%
Current year-36.02%
1 week 89.4
Extreme 89.4
95.74
1 month 89.4
Extreme 89.4
106.4
Current year 89.4
Extreme 89.4
192
1 year 89.4
Extreme 89.4
211.4
3 years 80
Extreme 80
334.7
5 years 80
Extreme 80
334.7
10 years 33.4
Extreme 33.4
334.7
Manager TitleAgeSince
Chief Executive Officer 63 -
Chief Executive Officer 60 01/06/2021
Director of Finance/CFO - 18/08/2026
Director TitleAgeSince
Director/Board Member 60 04/08/2014
Chairman 63 17/06/2021
Director/Board Member 60 13/10/2017
Date Insider Type Main position Quantity % Market Cap. Importance
09/09/24
Infinity Holdings
SellCompany 13,38,600 0.7992%
09/09/24
Infinity Holdings
SellCompany 6,63,586 0.3962%
Change 5-day change 1-year change 3-year change Capi.($)
+4.02%-0.62%-50.94%-42.58% 18Cr
+1.35%+0.21%+1.53%+66.72% 7.77TCr
+0.62%-0.47%+4.87%+17.15% 3.76TCr
+0.29%-5.44%-2.82%-23.86% 3.38TCr
+2.32%-1.05%+5.28%+7.32% 3.09TCr
+1.17%+1.10%+10.20%+48.31% 2.98TCr
+0.59%+2.06%-5.62%+21.15% 2.58TCr
+0.42%+1.09%+46.20%+37.10% 2.35TCr
+0.52%+1.55%+53.49%+24.68% 1.88TCr
+1.98%+1.76%-44.27%-39.68% 1.76TCr
Average +1.33%-1.74%+1.79%+11.63% 2.96TCr
Weighted average by Cap. +1.07%-1.50%+6.18%+26.58%

Financials

2027 *2028 *
Net sales 2.13TCr 22Cr 20Cr 18Cr 17Cr 31Cr 32Cr 221.25Cr 86Cr 1.09TCr 83Cr 81Cr 3.5TCr 2.36TCr 25Cr 22Cr 20Cr 18Cr 35Cr 35Cr 244.95Cr 95Cr 1.21TCr 92Cr 90Cr 3.88TCr
Net income 76Cr 79.39L 70.5L 66.06L 59.81L 1.13Cr 1.14Cr 7.93Cr 3.08Cr 39Cr 2.98Cr 2.92Cr 125.57Cr 156.75Cr 1.63Cr 1.44Cr 1.35Cr 1.23Cr 2.31Cr 2.33Cr 16Cr 6.31Cr 80Cr 6.11Cr 5.97Cr 257.3Cr
Net Debt - -
Projected Income Statement - Annual - Camlin Fine Sciences Limited
Logo Camlin Fine Sciences Limited
Camlin Fine Sciences Limited is an India-based specialty chemicals company, which is engaged in the research, development, manufacturing and marketing of specialty chemicals, ingredients, and additive blends. The Company's products portfolio is categorized into shelf-life solutions, performance chemicals, aroma ingredients, and health and wellness. Its products include catechol, tert-butylhydroquinone (TBHQ), Butylated Hydroxyanisole (BHA), Butylated Hydroxytoluene (BHT), Ascorbyl Palmitate (ASP), 4-Tertiary Butyl Catechol, Xtendra, Guaiacol, Para DiMethoxy Benzene, NaSure, Hydroquinone, and Veratrole. Its aroma ingredients mainly include Vanillin, Ethyl Vanillin, and Natural Vanillin. The Company's products are used in varied industries, such as human food, animal feed, pet food, agrochemicals, petrochemicals, pharmaceuticals, nutraceuticals, flavors and fragrances, and health care. Its brands include Ezential, Nasure, adorr, Dinamics, Xtendra, and Biosus.
Employees
674
Date Price Change Volume
06/26/06 ₹94.91 +4.02% 84,718
05/26/05 ₹91.24 +0.12% 22,193
01/26/01 ₹91.13 -2.06% 36,387
30/26/30 ₹93.05 -0.21% 23,651
29/26/29 ₹93.25 -2.36% 77,373
Trader
Investor
Global
Quality
ESG MSCI
-
Ratings Surperformance© - Camlin Fine Sciences Limited
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
94.91INR
Average target price
152.50INR
Spread / Average Target
+60.68%

Quarterly revenue - Rate of surprise

Rate of surprise - Net sales - Quarterly - Camlin Fine Sciences Limited
  1. Stock Market
  2. Stocks
  3. CAMLINFINE Stock